Live
CAC 40 · Healthcare ·

EssilorLuxottica (EL) formalises share dividend option for investors

EssilorLuxottica's annual general meeting on 1 June 2026 confirmed the option for shareholders to receive their dividends in shares, facilitating direct reinvestment in the company. This decision formalises a distribution method previously discussed by the French eyewear manufacturer.

The emission price for these new shares has been set at €175.06 per title. A total of 957,954 new shares will be issued, representing 0.21% of EssilorLuxottica's share capital. Settlement and delivery of these securities are scheduled for 3 June 2026.

On 2 June 2026, EssilorLuxottica shares are trading at €170.40, a decline of 1.4%. This movement follows a previous closing price of €172.80 yesterday, 1 June. The stock has seen a broader decline since the company's earlier communication regarding the issuance of new shares for dividend payments.

What Does It Mean

Why a Stock Dividend Option Can Dilute Share Value

EssilorLuxottica is a global leader in eyewear, designing, manufacturing, and distributing corrective lenses, sunglasses, and frames. They boast a portfolio of renowned brands such as Ray-Ban and Oakley, alongside prestigious licensed names. Their customer base spans independent opticians, major retail chains, and a growing direct-to-consumer segment through their own stores and online platforms. This integrated model allows them to generate revenue at every stage, from production to final sale.

The slight dip in the share price today, 2 June 2026, stems from yesterday's confirmation of a stock dividend option. This decision, approved at the general meeting, means that new shares will be issued, allowing shareholders to reinvest directly into the company. In total, 957,954 additional shares, representing 0.21% of EssilorLuxottica's share capital, will be created. These new shares have an emission price set at €175.06 each, with delivery scheduled for 3 June 2026.

This increase in the number of shares circulating naturally tends to dilute the value of existing holdings, putting downward pressure on the stock price. EssilorLuxottica is currently trading at €170.40, marking a 1.4% decrease from its previous close of €172.80.

Imagine you own a piece of a valuable artwork. If the artist decides to create more identical pieces and distribute them without the original artwork growing in size or value, then your individual piece, while still valuable, now represents a slightly smaller fraction of the total collection. This is similar to what happens when new shares are issued for a dividend, even if it offers flexibility to investors.

Tags

EssilorLuxottica

EL·Euronext Paris·CAC 40·🇫🇷
Industry
Medical - Instruments & Supplies
CEO
Francesco Milleri
Employees
153,498
Headquarters
Paris, FR
Listed
2000
About

EssilorLuxottica S.A. (EL) is a global leader in ophthalmic products, specialising in the design, manufacture, and distribution of lenses, frames, and sunglasses. Its operations span North America, Europe, Latin America, Asia, Oceania, and Africa, organised across five key segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The company's diverse portfolio includes well-known lens brands such as Varilux, Crizal, and Transitions, alongside optical instruments for professionals. Its Equipment division supplies digital surfacing and lens coating machines. The Sunglasses and Readers segment offers a wide array of non-prescription eyewear under various brands, including Foster Grant and Bolon. With a network of 490 prescription laboratories and edging-mounting facilities, EssilorLuxottica was founded in 1849 and is headquartered in Paris, France.